Hannover Medical School
Reports describe recent advances in diabetic nephropathy research
Published in Cardiovascular Business Week, July 5th, 2005
Study 1: A chronic angiotensin II receptor blockade reduces intrarenal vascular resistance in patients with type 2 diabetes.
"Increased (intra)renal activity of the renin-angiotensin system may cause a persistent increase in renovascular resistance and intraglomerular pressure in patients with diabetes, thus contributing to the development of diabetic renal damage. The effect of chronic angiotensin II subtype I receptor blockade on (intra)renal hemodynamics in patients with type 2 diabetes was examined in a double-blind parallel group study. Patients were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Biosensors International Group, Ltd.
Medical device maker reports significant increase in revenue - Edwards Lifesciences
Agreement between PVT and 3F Therapeutics restructured in light of acquisition - Martek Biosciences Corporation
Biosciences corporation announces second quarter financial results - Osiris Therapeutics, Inc.
Adult stem cell therapy company finalizes investment round - OXIS International, Inc.
Company focused on diseases of oxidative stress discusses financials - Aarhus University Hospital
Research in diabetes pathogenesis provides new insights - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
